United-Guardian (NASDAQ:UG) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of United-Guardian (NASDAQ:UGGet Free Report) in a research note issued on Friday. The brokerage set a “buy” rating on the stock.

United-Guardian Trading Down 0.5 %

Shares of NASDAQ:UG opened at $9.15 on Friday. United-Guardian has a 12-month low of $7.35 and a 12-month high of $16.25. The stock’s 50-day moving average price is $10.32 and its two-hundred day moving average price is $11.27. The firm has a market cap of $42.04 million, a price-to-earnings ratio of 12.04 and a beta of 0.73.

United-Guardian (NASDAQ:UGGet Free Report) last released its quarterly earnings data on Friday, March 21st. The company reported $0.11 EPS for the quarter. The company had revenue of $2.48 million for the quarter. United-Guardian had a return on equity of 30.25% and a net margin of 28.30%.

Hedge Funds Weigh In On United-Guardian

A number of hedge funds have recently added to or reduced their stakes in the business. Northern Trust Corp raised its stake in shares of United-Guardian by 69.5% during the fourth quarter. Northern Trust Corp now owns 25,527 shares of the company’s stock valued at $244,000 after purchasing an additional 10,466 shares in the last quarter. United Capital Financial Advisors LLC acquired a new stake in shares of United-Guardian in the fourth quarter worth $192,000. Renaissance Technologies LLC lifted its position in United-Guardian by 4.3% in the 4th quarter. Renaissance Technologies LLC now owns 190,163 shares of the company’s stock worth $1,818,000 after buying an additional 7,800 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of United-Guardian by 10.3% during the 4th quarter. Geode Capital Management LLC now owns 31,264 shares of the company’s stock valued at $302,000 after buying an additional 2,929 shares during the last quarter. Finally, Heron Bay Capital Management acquired a new position in United-Guardian during the fourth quarter worth $135,000. Institutional investors and hedge funds own 23.16% of the company’s stock.

About United-Guardian

(Get Free Report)

United-Guardian, Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.

Featured Stories

Receive News & Ratings for United-Guardian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian and related companies with MarketBeat.com's FREE daily email newsletter.